source
- #ADA26: Roche's incretin shot works in mid-stage trial in type 1 diabetesA daily incretin shot being developed by Roche has shown promise in type 1 diabetes — the form that is not generally believed to be directly treatable by GLP-1-based drugs. According to Phase 2 dat…Endpoints · 1mo ago↗ source
- CDC: Ebola outbreak in Central Africa could reach 20,000 cases without strong countermeasuresThe Ebola outbreak in Central Africa could grow to 20,000 cases or more, depending on how quickly infected people are isolated to slow the spread, according to a new U.S. analysis.STAT · 1mo ago↗ source
- STAT+: Newer GLP-1s, pushback on research cuts, and a protestYou're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.STAT